RON-targeted antibody-drug conjugate therapy eliminates cancer stem-like cells and induces long-term tumor regressions in preclinical models of triple-negative breast cancer.

被引：0
|
作者：
Suthe, Sreedhar Reddy [1 ,2 ,3 ]
Yao, Hang-Ping [4 ]
Wang, Ming-Hai [1 ,2 ,3 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Res Ctr, Amarillo, TX USA
[2] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA
[3] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China
来源：
CANCER IMMUNOLOGY RESEARCH | 2020年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B54
引用
收藏
页码：108 / 108
页数：1
相关论文
共 26 条
  • [1] RON-Targeted Antibody-Drug Conjugate Therapy Ablates Cancer Stem Cells and Induces Longterm Tumor Regressions in Preclinical Models of Triple Negative Breast Cancer
    Suthe, S.
    Yao, H.
    Wang, M.
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (10): : 2411 - 2412
  • [2] RON Receptor-Targeted Antibody-Drug Conjugate Therapy Ablates Cancer Stem Cells and Induces Long-term Tumor Regressions in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
    Suthe, Sreedhar Reddy
    Yao, Hang-Ping
    Wang, Ming-Hai
    FASEB JOURNAL, 2019, 33
  • [3] Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy
    Si, Yingnan
    Xu, Yuanxin
    Guan, JiaShiung
    Chen, Kai
    Kim, Seulhee
    Yang, Eddy S.
    Zhou, Lufang
    Liu, Xiaoguang Margaret
    ENGINEERING IN LIFE SCIENCES, 2021, 21 (1-2): : 37 - 44
  • [4] RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells
    Suthe, Sreedhar Reddy
    Yao, Hang-Ping
    Weng, Tian-Hao
    Wang, Ming-Hai
    CURRENT CANCER DRUG TARGETS, 2023, 23 (02) : 103 - 117
  • [5] 3D Bioprinted Tumor-Stroma Models of Triple-Negative Breast Cancer Stem Cells for Preclinical Targeted Therapy Evaluation
    Gonzalez-Callejo, Patricia
    Garcia-Astrain, Clara
    Herrero-Ruiz, Ada
    Henriksen-Lacey, Malou
    Seras-Franzoso, Joaquin
    Abasolo, Ibane
    Liz-Marzan, Luis M.
    ACS APPLIED MATERIALS & INTERFACES, 2024, 16 (21) : 27151 - 27163
  • [6] NEAT1 enhances drug sensitivity by inhibiting cancer stem-like cells in triple-negative breast cancer
    Kwong, A.
    Chen, J.
    Siu, J.
    Chuek, I.
    Shin, V.
    CANCER RESEARCH, 2019, 79 (04)
  • [7] Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer
    Huang, Wenpeng
    Li, Liming
    Zhou, Yuhan
    Yang, Qi
    Mixdorf, Jason C.
    Barnhart, Todd E.
    Hsu, Jessica C.
    Saladin, Rachel J.
    Liu, Chihao
    Rosenkrans, Zachary T.
    Engle, Jonathan W.
    Gao, Jianbo
    Kang, Lei
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [8] Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem-Like Behavior in Triple-Negative Breast Cancer Cells
    Hoover, Elise C.
    Day, Emily S.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2025, 113 (01)
  • [9] IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results
    Goldenberg, David M.
    Vahdat, Linda T.
    Starodub, Alexander N.
    Bardia, Aditya
    Chuang, Ellen
    Moroose, Rebecca L.
    Diamond, Jennifer R.
    Sharkey, Robert M.
    Maliakal, Pius P.
    Hamburger, Steven A.
    Ocean, Allyson J.
    CANCER RESEARCH, 2015, 75
  • [10] Density Gradient Centrifugation Is an Effective Tool to Isolate Cancer Stem-like Cells from Hypoxic and Normoxia Triple-Negative Breast Cancer Models
    Sargiacomo, Camillo
    Klepinin, Aleksandr
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
123